Ads

You May Also Like

Interpace Diagnostics Expands Application of Pancreatic Cancer Test

PancraGEN® Gaining Further Guideline Support and Expanded Use for Multiple New IndicationsPARSIPPANY, N.J., July ...

ContraFect Appoints Lisa Ricciardi as Chief Operating Officer

YONKERS, N.Y., Oct. 05, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company ...